Allergol Immunopathol (Madr):希腊患有过敏性鼻炎儿童中的儿童睡眠习惯调查问卷研究

2018-01-30 AlexYang MedSci原创

阻塞性呼吸系统疾病,比如过敏性鼻炎和哮喘也许会损伤睡眠质量。最近,有研究人员研究确定了儿童睡眠习惯调查问卷(CSHQ),研究对象为希腊6到14岁的儿童。到目前为止,还没有检验过的工具来评估希腊入学儿童的睡眠障碍。研究人员调查了CSHQ在一个患有过敏性鼻炎(AR)的样本中的可靠性和正确性,并且委托这些儿童的父母作为一个非临床群体,通过儿科过敏性鼻炎生活质量(PedARQol)调查问卷来间接地对儿童的

阻塞性呼吸系统疾病,比如过敏性鼻炎和哮喘也许会损伤睡眠质量。最近,有研究人员研究确定了儿童睡眠习惯调查问卷(CSHQ),研究对象为希腊6到14岁的儿童。到目前为止,还没有检验过的工具来评估希腊入学儿童的睡眠障碍。

研究人员调查了CSHQ在一个患有过敏性鼻炎(AR)的样本中的可靠性和正确性,并且委托这些儿童的父母作为一个非临床群体,通过儿科过敏性鼻炎生活质量(PedARQol)调查问卷来间接地对儿童的AR生活质量(Qol)进行测量。研究发现,当关联到PedARQol(CF,)CSHQ调查问卷的儿童版(CF)具有一定的内部相容性,克隆巴赫系数为0.671,格特曼分半系数为0.563,且在2个群体调查问卷响应中,存在着一定的组内相关性(ICC=0.505)。CSHQ父母版本(PF)具有非常好的内部相容性,克隆巴赫系数为0.928,格特曼分半系数为0.798,并且在2个群体调查响应中具有高度的组内相关性(ICC=0.643)。

最后,研究人员指出,CSHQ CF希腊版本,尤其是PF是一款可依赖的临床工具,可以用来评估因阻塞性呼吸障碍引起的学龄儿童睡眠障碍睡眠质量的评估,比如AR。

原始出处:

Mavroudi A, Chrysochoou EA, Boyle RJ et al. Validation of the Children's Sleep Habits Questionnaire in a sample of Greek children with allergic rhinitis. Allergol Immunopathol (Madr). 12 Jan 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2046936, encodeId=86ce2046936e5, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Oct 20 05:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949477, encodeId=9aa619494e71b, content=<a href='/topic/show?id=af57e297647' target=_blank style='color:#2F92EE;'>#睡眠习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72976, encryptionId=af57e297647, topicName=睡眠习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 14 00:50:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786198, encodeId=f7fe1e86198eb, content=<a href='/topic/show?id=569f13e9045' target=_blank style='color:#2F92EE;'>#Pathol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13790, encryptionId=569f13e9045, topicName=Pathol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 16 11:50:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329077, encodeId=a20113290e76d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486869, encodeId=6ad7148686909, content=<a href='/topic/show?id=cac69203415' target=_blank style='color:#2F92EE;'>#调查问卷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92034, encryptionId=cac69203415, topicName=调查问卷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a81b8226286, createdName=10518096zz, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542065, encodeId=2eb01542065a6, content=<a href='/topic/show?id=d15d484e110' target=_blank style='color:#2F92EE;'>#希腊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48471, encryptionId=d15d484e110, topicName=希腊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740213344258, createdName=ms117281293605716, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2046936, encodeId=86ce2046936e5, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Oct 20 05:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949477, encodeId=9aa619494e71b, content=<a href='/topic/show?id=af57e297647' target=_blank style='color:#2F92EE;'>#睡眠习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72976, encryptionId=af57e297647, topicName=睡眠习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 14 00:50:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786198, encodeId=f7fe1e86198eb, content=<a href='/topic/show?id=569f13e9045' target=_blank style='color:#2F92EE;'>#Pathol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13790, encryptionId=569f13e9045, topicName=Pathol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 16 11:50:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329077, encodeId=a20113290e76d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486869, encodeId=6ad7148686909, content=<a href='/topic/show?id=cac69203415' target=_blank style='color:#2F92EE;'>#调查问卷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92034, encryptionId=cac69203415, topicName=调查问卷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a81b8226286, createdName=10518096zz, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542065, encodeId=2eb01542065a6, content=<a href='/topic/show?id=d15d484e110' target=_blank style='color:#2F92EE;'>#希腊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48471, encryptionId=d15d484e110, topicName=希腊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740213344258, createdName=ms117281293605716, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2046936, encodeId=86ce2046936e5, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Oct 20 05:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949477, encodeId=9aa619494e71b, content=<a href='/topic/show?id=af57e297647' target=_blank style='color:#2F92EE;'>#睡眠习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72976, encryptionId=af57e297647, topicName=睡眠习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 14 00:50:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786198, encodeId=f7fe1e86198eb, content=<a href='/topic/show?id=569f13e9045' target=_blank style='color:#2F92EE;'>#Pathol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13790, encryptionId=569f13e9045, topicName=Pathol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 16 11:50:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329077, encodeId=a20113290e76d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486869, encodeId=6ad7148686909, content=<a href='/topic/show?id=cac69203415' target=_blank style='color:#2F92EE;'>#调查问卷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92034, encryptionId=cac69203415, topicName=调查问卷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a81b8226286, createdName=10518096zz, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542065, encodeId=2eb01542065a6, content=<a href='/topic/show?id=d15d484e110' target=_blank style='color:#2F92EE;'>#希腊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48471, encryptionId=d15d484e110, topicName=希腊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740213344258, createdName=ms117281293605716, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]
    2018-12-16 docwu2019
  4. [GetPortalCommentsPageByObjectIdResponse(id=2046936, encodeId=86ce2046936e5, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Oct 20 05:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949477, encodeId=9aa619494e71b, content=<a href='/topic/show?id=af57e297647' target=_blank style='color:#2F92EE;'>#睡眠习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72976, encryptionId=af57e297647, topicName=睡眠习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 14 00:50:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786198, encodeId=f7fe1e86198eb, content=<a href='/topic/show?id=569f13e9045' target=_blank style='color:#2F92EE;'>#Pathol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13790, encryptionId=569f13e9045, topicName=Pathol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 16 11:50:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329077, encodeId=a20113290e76d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486869, encodeId=6ad7148686909, content=<a href='/topic/show?id=cac69203415' target=_blank style='color:#2F92EE;'>#调查问卷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92034, encryptionId=cac69203415, topicName=调查问卷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a81b8226286, createdName=10518096zz, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542065, encodeId=2eb01542065a6, content=<a href='/topic/show?id=d15d484e110' target=_blank style='color:#2F92EE;'>#希腊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48471, encryptionId=d15d484e110, topicName=希腊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740213344258, createdName=ms117281293605716, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]
    2018-02-01 膀胱癌
  5. [GetPortalCommentsPageByObjectIdResponse(id=2046936, encodeId=86ce2046936e5, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Oct 20 05:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949477, encodeId=9aa619494e71b, content=<a href='/topic/show?id=af57e297647' target=_blank style='color:#2F92EE;'>#睡眠习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72976, encryptionId=af57e297647, topicName=睡眠习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 14 00:50:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786198, encodeId=f7fe1e86198eb, content=<a href='/topic/show?id=569f13e9045' target=_blank style='color:#2F92EE;'>#Pathol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13790, encryptionId=569f13e9045, topicName=Pathol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 16 11:50:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329077, encodeId=a20113290e76d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486869, encodeId=6ad7148686909, content=<a href='/topic/show?id=cac69203415' target=_blank style='color:#2F92EE;'>#调查问卷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92034, encryptionId=cac69203415, topicName=调查问卷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a81b8226286, createdName=10518096zz, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542065, encodeId=2eb01542065a6, content=<a href='/topic/show?id=d15d484e110' target=_blank style='color:#2F92EE;'>#希腊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48471, encryptionId=d15d484e110, topicName=希腊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740213344258, createdName=ms117281293605716, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2046936, encodeId=86ce2046936e5, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Oct 20 05:50:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949477, encodeId=9aa619494e71b, content=<a href='/topic/show?id=af57e297647' target=_blank style='color:#2F92EE;'>#睡眠习惯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72976, encryptionId=af57e297647, topicName=睡眠习惯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Mar 14 00:50:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786198, encodeId=f7fe1e86198eb, content=<a href='/topic/show?id=569f13e9045' target=_blank style='color:#2F92EE;'>#Pathol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13790, encryptionId=569f13e9045, topicName=Pathol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Dec 16 11:50:00 CST 2018, time=2018-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329077, encodeId=a20113290e76d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486869, encodeId=6ad7148686909, content=<a href='/topic/show?id=cac69203415' target=_blank style='color:#2F92EE;'>#调查问卷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92034, encryptionId=cac69203415, topicName=调查问卷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a81b8226286, createdName=10518096zz, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542065, encodeId=2eb01542065a6, content=<a href='/topic/show?id=d15d484e110' target=_blank style='color:#2F92EE;'>#希腊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48471, encryptionId=d15d484e110, topicName=希腊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=740213344258, createdName=ms117281293605716, createdTime=Thu Feb 01 11:50:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]

相关资讯

Allergol Immunopathol (Madr):在过敏性鼻炎儿童中,小气道功能紊乱发生于哮喘发生之前

流行病学证据表明了过敏性鼻炎(AR)与哮喘存在着直接的联系。一些研究同样支持了患有AR且没有哮喘的儿童中小气道功能紊乱(SAD)的存在。然而,是否SAD能够预测AR到哮喘的发展仍旧未知。最近,有研究人员探索了在非哮喘AR儿童中SAD的情况,并且评估了SAD预测哮喘的能力。研究包括了73名6岁大的儿童,他们患有间歇性的中度到重度AR,但是在前2年时间没有哮喘症状或者治疗。这些儿童经历了呼吸量测定、呼

Am J Rhinol Allergy:利用鼻腔细胞学和免疫球蛋白E抗体水平对过敏性鼻炎症候的评估

在婴幼儿中鉴定过敏性鼻炎的症候是困难的,因为做出一个总结性的诊断具有挑战。研究人员利用鼻拭子中细胞的差异和对食物和吸入性过敏原的免疫球蛋白E(slgE)抗体水平值来进行诊断,并且鉴定了相关的过敏原来对过敏性鼻炎的症候进行了调查。研究包括了302名儿童,年龄在2到120个月,并且他们都因流鼻涕而在他们的诊所治疗。研究发现,参与者在2-14个月(n=84)、15-24个月(n=57)、 25-60 个

Otolaryngol Head Neck Surg:单独口服抗组胺药或组合白三烯素阻断剂对过敏性鼻炎治疗的分析

最近,有研究人员评估了是否基于口服抗组胺药物(H1)的白三烯素阻断剂(LTRAs)辅助疗法能够增加过敏性鼻炎(AR)治疗的效果。数据搜索包括了 PubMed、EMBASE和CENTRAL数据库的数据,截止日期到2017年9月。那些随机对照试验(RCTs)比较了LTRAs+H1和H1治疗结果的试验是符合要求的。研究人员利用加权均数差(WMD)和95%置信区间(CI)测量了汇集比较影响,还预先设定了亚

Allergol Immunopathol (Madr):结合粉尘螨滴剂的舌下免疫治疗在学龄前后过敏性鼻炎儿童中的效果和安全性评估

舌下免疫治疗(SLIT)的安全性和治疗效果已经被许多研究证实。然而,在中国关于舌下免疫治疗在过敏性鼻炎(AR)儿童中的效果和安全性研究仍旧很少。最近,有研究人员进行了回顾性的研究,目的是评估结合粉尘螨滴剂的SLIT疗法在患有AR的学龄前后儿童中的效果和安全性情况。研究包括了282名年龄在2-13岁的受试者,他们接受了为期2年的舌下免疫治疗过程,并且结合了药物治疗。研究人员根据年龄,将病人分为学龄前

Allergy:利用移动技术对过敏性鼻炎治疗情况的分析

大规模的观察互补研究是需要的,从而三角化来自随机对照试验(RCTs)中的发现,因为这些发现反应了真实世界中每天的实际情况。在一个先导性的研究中,研究人员尝试利用移动技术,为真实生活中过敏性鼻炎的治疗提供额外的和互补的认识。研究人员利用一款移动手机应用软件对日常数据进行了搜集。在2015年和2016年,共有2871名使用者填写了视觉模拟评分法(VAS),包括了17091天的数据。药物治疗情况包括了9

Allergy:中国北方草原高度花粉接触情况下的花粉诱导的过敏性鼻炎流行度分析

最近,有研究人员调查了流行病学和医生诊断的花粉诱导的AR(PiAR)在中国北部草原中的流行度情况,并且研究了密度和花粉接触时间对PiAR流行度的影响。研究总共包括了6043名受试者,并且完成了研究,其中32.4%的受试者为流行病学AR,18.5%的受试者为PiAR。流行度在男性中要比女性更高(19.6% vs 17.4%, P=0.024),但是在2个主要居住和种族之间没有差异(汉族和蒙古族)。来